News

Abdera Therapeutics Announces FDA Clearance of IND Application for ABD-147

View more

May 31, 2024

PSMA-PET/CT effective in patients with kidney cancer

View more

May 31, 2024

Study: PSMA PET/CT Agent May Rule Out csPCa in 93 Percent of PI-RADS 3 Lesions

View more

May 31, 2024

Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer

View more

May 24, 2024

Investigating Absorbed Dose Response in 177Lu-DOTATATE for GEP-NETs

View more

May 24, 2024

Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients

View more

Apr 26, 2024